Mona Loutfy, MD - PowerPoint PPT Presentation

1 / 17
About This Presentation
Title:

Mona Loutfy, MD

Description:

Women and HIV: New Canadian HIV Pregnancy Planning Guidelines Mona Loutfy, MD Maple Leaf Medical Clinic & Women s College Hospital – PowerPoint PPT presentation

Number of Views:158
Avg rating:3.0/5.0
Slides: 18
Provided by: Mona186
Category:

less

Transcript and Presenter's Notes

Title: Mona Loutfy, MD


1
Women and HIV New Canadian HIV Pregnancy
Planning Guidelines
  • Mona Loutfy, MD
  • Maple Leaf Medical Clinic Womens College
    Hospital

2
Pregnancy planning
  • Since there is
  • ? mortality and morbidity overall related to HIV
    (life expectancy on average 45-50 years from
    diagnosis with ARVs)
  • ? prevalence of women who are HIV-positive (51
    globally, 22 in Canada)
  • Majority of HIV-positive women and men of
    reproductive age gt 80
  • Methods to reduce the chance of vertical
    transmission to lt 1

Persons living with HIV are going to be
interested in PREGNANCY PLANNING
3
Fertility Desires Intentions
N 490 Ontario HIV women of reproductive age
Outcome
Fertility desired (N 475) 69 (95 CIs, 64-73)
0 31
1 32
2 37
Fertility intended (N 465) 57 (95 CIs, 53-62)
0 43
1 26
2 31
Fertility actions (N 456)
Approached partner 32
Approached doctor 26
Stopped BC to become pregnant 12
Loutfy et al. PloS ONE 2009
4
The Canadian HIV Fertility Program
  • Goal
  • To have the discussion of pregnancy,
    reproduction, pre-conception planning as part of
    routine HIV care Between all HCP HIV-positive
    patients
  • Why
  • We want pregnancies to HIV-positive women to be
    planned to improve maternal infant health, and
    reduce vertical and horizontal transmission
  • Allow for discussion of contraception, sexual
    health, harm transmission reduction,
    criminalization

5
Canadian HIV Pregnancy Planning Guidelines
6
Counseling - Pregnancy Planning and HIV
  • Fertility and HIV
  • Four main issues need to be considered
  • 1) Prevention of vertical transmission
  • Viral transmission from the mother to the child
  • 2) Healthy pre-conception
  • 3) Prevention of horizontal transmission
  • Viral transmission between partners or
    interacting individuals
  • 4) Fertility issues
  • If the individual or couple has infertility

Picture from http//www.tthhivclinic.com/overview
_home.htm 1Perinatal HIV Guidelines Working Group
2007 http//aidsinfo.nih.gov/ContentFiles/Perinata
lGL.pdf.
7
Prevention of Vertical Transmission
  • Guidelines July 31, 2012
  • Centers for Disease Control and Prevention. U.S.
    Public Health Service Task Force recommendations
    for use of antiretroviral drugs in pregnant
    HIV-1-infected women for maternal health and
    interventions to reduce perinatal HIV-1
    transmission in the United States.
  • Including use of ARVs C/S and not breastfeeding
  • Up to date guidelines http//aidsinfo.nih.gov/gui
    delines

8
More Potent Antiretroviral Regimens
areAssociated with Lower Perinatal Transmission
Women Infants Transmission Study, 1990-1999
Cooper, E. et al. JAIDS 200229484-94
9
General Principles for Pregnancy Planning
  • Taking Folic Acid 1 mg a day for 3 months before
    and during 1st trimester of pregnancy
  • Not smoking and drinking
  • Maintaining a balanced diet
  • Terminating the use of recreational drugs

10
HIV Pre-conception Counseling
  • Future mother have to stop any teratogenic drugs
    months before planned conception (e.g. Sustiva
    for at least 2 months)
  • Future mother and father should not have received
    HCV treatment for 6 months before conception
  • If requires ARVs for mothers health, recommended
    for woman to be taking ARVs with VL lt 50
    copies/mL before becoming pregnant

11
Prevention of Horizontal Transmission
  • Different clinical scenarios
  • HIV woman with HIV- man (serodiscordant) or who
    is single or in same sex relationship
  • HIV man and HIV- woman (serodiscordant)
  • HIV man and woman (seroconcordant)
  • HIV man who is single or in same sex
    relationship or couple seeking egg donation or
    surrogate mother
  • Different clinical scenarios have different risk
    and require different strategies to prevent
    horizontal transmission

12
All Scenarios
  • Review all different options for insemination/
    conception method continuum of risk including
  • Unprotected intercourse (on ART, full viral
    suppression)
  • Unprotected intercourse with timed ovulation (on
    ART, full viral suppression)
  • Home insemination (i.e. turkey baster method)
  • Intrauterine insemination (IUI) (in fertility
    clinic)
  • Sperm washing followed by IUI
  • Other IVF, ICSI, gestational carrier, adoption

13
Fertility Issues
  • Possibly increased in HIV Age issue
  • Fertility investigations
  • Options for fertility treatment
  • Ovulation stimulating drugs
  • Intrauterine Insemination (IUI)
  • In Vitro Fertilization (IVF)
  • Intracytoplasmic Sperm Injection (ICSI)

14
Access to Fertility Services in Canada
  • Fertility treatments available
  • Any combination of Rx offered in 12/23 (52)
    clinics
  • Most common IUI
  • Full fertility services for HIV women
  • Full services are more limited
  • IVF available in only 4/23 (17) clinics
  • 1 in AB, 3 in ON
  • Limited treatments available for risk reduction
  • Depends on couple scenario
  • M/F- M-/F ?10/23 (43) M/F ?6/23 (26)
  • Sperm washing - only 6/23 (26) clinics

Yudin, Shapiro, Loutfy. Reprod Health 2010
15
Fertility clinic access in Quebec long story
Finally officially available - Government decide
to have one clinic providing care to patients
with infectious samples including HIV in Montreal
Dr. Jacques Kadoch CHUM Saint Luc
Hospital Gynecology Clinic Fertility
Clinic Phone 1-514-890-8355 ext. 2 Fax
1-514-412-7455 Entrance via Édouard-Asselin
Pavilion 264, René-Lévesque Blvd. East 6th
Floor Montreal (Quebec) H2X 1P1
16
Pamphlets Pregnancy Planning
  • Available in French English at www.catie.ca

17
Acknowledgements
  • Thank you to Anita, Benoit, Nadia OBrien,
    Johanna Lewis Women for Positive Action for
    help with the slides
  • Thank you to CHIWOSs co-PIs, and the entire
    national core research team
  • Also to the PRAs, Steering Committee members
  • Thank you to the Research Team, CAB members and
    collaborators
  • Thank you to Canadian Institutes of Health
    Research, Womens College Hospital and the
    University of Toronto
  • Thank you to our affiliates CANOC and Reach
  • Thank you to our funders CIHR and CTN
Write a Comment
User Comments (0)
About PowerShow.com